Ledger.Open graph →
SEC Form D · Amendment · filed June 6, 2013

Relmada Therapeutics, Inc

Offering
$8.0M
Sold
$5.0M
Exemption
—
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

People & firms on this filing (2)

Sergio Traversa · New York, NYExec · DirectorSandesh Seth · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗